Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma

The deletion of 12p (del(12p)) has been described as a novel negative prognostic marker in multiple myeloma (MM) and has gained increasing attention in recent years. However, its impact on MM is still controversial. In this study, we comprehensively evaluated the clinical impact of 12p13 deletion us...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Li, Fei, Xu, Yan, Deng, Ping, Yang, Ye, Sui, Weiwei, Jin, Fengyan, Hao, Mu, Li, Zengjun, Zang, Meirong, Zhou, Dehui, Gu, Zhimin, Ru, Kun, Wang, Jianxiang, Cheng, Tao, Qiu, Lugui
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2015
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496228/
https://ncbi.nlm.nih.gov/pubmed/25831238
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky